X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (98) 98
animals (84) 84
female (76) 76
cancer (65) 65
breast cancer (64) 64
index medicus (62) 62
oncology (57) 57
mice (42) 42
medicine & public health (28) 28
breast (24) 24
cell biology (23) 23
endocrinology & metabolism (23) 23
breast neoplasms - metabolism (22) 22
tumors (22) 22
breast neoplasms - pathology (21) 21
cancer research (21) 21
breast neoplasms (20) 20
biochemistry & molecular biology (19) 19
breast neoplasms - drug therapy (19) 19
cell line, tumor (17) 17
physiology (17) 17
mammary neoplasms, experimental - drug therapy (16) 16
mammary neoplasms, experimental - pathology (16) 16
rats (16) 16
antineoplastic agents - therapeutic use (15) 15
expression (15) 15
mammary cancer (15) 15
mammary cancers (15) 15
mammary gland (15) 15
research (15) 15
apoptosis (14) 14
article (14) 14
breast carcinoma (14) 14
breast carcinomas (14) 14
breast malignant neoplasm (14) 14
breast malignant neoplasms (14) 14
breast malignant tumor (14) 14
breast malignant tumors (14) 14
breast neoplasm (14) 14
breast tumor (14) 14
breast tumors (14) 14
cancer of breast (14) 14
cancer of the breast (14) 14
cancer, breast (14) 14
cancer, mammary (14) 14
cancers, mammary (14) 14
carcinoma, breast (14) 14
carcinoma, human mammary (14) 14
carcinomas, breast (14) 14
carcinomas, human mammary (14) 14
care and treatment (14) 14
human mammary carcinoma (14) 14
human mammary carcinomas (14) 14
human mammary neoplasm (14) 14
human mammary neoplasms (14) 14
male (14) 14
malignant neoplasm of breast (14) 14
malignant tumor of breast (14) 14
mammary carcinoma, human (14) 14
mammary carcinomas, human (14) 14
mammary neoplasm, human (14) 14
mammary neoplasms, human (14) 14
neoplasm, breast (14) 14
neoplasm, human mammary (14) 14
neoplasms, breast (14) 14
neoplasms, human mammary (14) 14
tumor, breast (14) 14
tumors, breast (14) 14
cell proliferation - drug effects (13) 13
health aspects (13) 13
mammary neoplasms, experimental - metabolism (13) 13
metastasis (13) 13
pathology (13) 13
gene-expression (12) 12
in-vitro (12) 12
mamas (12) 12
mammary epithelial-cells (12) 12
neoplasms - drug therapy (12) 12
physiological aspects (12) 12
analysis (11) 11
antineoplastic agents - pharmacology (11) 11
breast-cancer (11) 11
lactation (11) 11
mammary glands (11) 11
mammary-gland (11) 11
pharmacology & pharmacy (11) 11
signal transduction (11) 11
carcinoma (10) 10
cell proliferation (10) 10
cells (10) 10
development and progression (10) 10
diagnosis (10) 10
diseases (10) 10
epithelial-cells (10) 10
proteins (10) 10
adult (9) 9
breast diseases (9) 9
breast neoplasms - genetics (9) 9
breasts (9) 9
cell division - drug effects (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Pathology (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 05/2016, Volume 27, Issue 5, pp. 920 - 926
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
International Journal of Oral and Maxillofacial Surgery, ISSN 0901-5027, 07/2019, Volume 48, Issue 7, pp. 865 - 868
Mammary analogue secretory carcinoma (MASC) has recently been recognized as a salivary gland tumour that is characterized by the ETV6–NTRK3 fusion gene. A case... 
mammary analogue secretory carcinoma | bioradiotherapy | parotid gland | ETV6–NTRK3 fusion gene | SURGERY | ETV6-NTRK3 fusion gene | DENTISTRY, ORAL SURGERY & MEDICINE | SALIVARY-GLANDS | Medical colleges | Breast cancer | Carcinoma | Metastasis | Cancer
Journal Article
International journal of surgical pathology, 10/2017, Volume 25, Issue 7, p. 613
Salivary gland secretory carcinoma is usually a low-grade neoplasm. However, high-grade transformation can occur and has important implications for clinical... 
Immunohistochemistry | Translocation, Genetic | Pleural Neoplasms - genetics | Pyrazoles - therapeutic use | Parotid Gland - surgery | Salivary Gland Neoplasms - genetics | Humans | Pleural Neoplasms - diagnosis | Drug Resistance, Neoplasm | Male | Myoepithelioma - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Mammary Analogue Secretory Carcinoma - genetics | Mammary Analogue Secretory Carcinoma - secondary | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Fatal Outcome | Mammary Analogue Secretory Carcinoma - diagnosis | Adult | Pyrazoles - pharmacology | Pyridines - therapeutic use | Myoepithelioma - diagnosis | Pleural Neoplasms - secondary | Diagnosis, Differential | Cyclin-Dependent Kinase Inhibitor p18 - deficiency | Mammary Analogue Secretory Carcinoma - therapy | Cyclin-Dependent Kinase Inhibitor p15 - deficiency | Treatment Outcome | Adenocarcinoma, Clear Cell - diagnosis | Parotid Gland - pathology | Pleural Neoplasms - therapy | Disease Progression | Salivary Gland Neoplasms - diagnosis | Magnetic Resonance Imaging | Cyclin-Dependent Kinase Inhibitor p18 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Oncogene Proteins, Fusion - genetics | Gene Rearrangement | Salivary Gland Neoplasms - therapy | Adenocarcinoma, Clear Cell - pathology | Pyridines - pharmacology | Salivary Gland Neoplasms - pathology
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1723 - 19
The senescence-associated secretory phenotype (SASP) can be provoked by side effects of therapeutic agents, fueling advanced complications including cancer... 
CHEMOSENSITIVITY | NETWORK | PARACRINE SENESCENCE | EPITHELIAL-CELL LINE | MULTIDISCIPLINARY SCIENCES | INFLAMMATORY CYTOKINE SECRETION | TUMORIGENESIS | CANCER-THERAPY RESISTANCE | TUMOR MICROENVIRONMENT | DAMAGE | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Stromal Cells - pathology | Humans | Lung Neoplasms - metabolism | Male | Lactones - pharmacology | Prostate - pathology | Prostate - drug effects | Carcinoma, Ductal - metabolism | MAP Kinase Kinase Kinases - antagonists & inhibitors | Mammary Glands, Human - drug effects | DNA-Binding Proteins - antagonists & inhibitors | Everolimus - pharmacology | Signal Transduction | MAP Kinase Kinase Kinases - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Epithelial Cells - pathology | Mammary Glands, Human - pathology | MAP Kinase Kinase Kinases - metabolism | Breast Neoplasms - drug therapy | Phenotype | Breast Neoplasms - genetics | Mice | Mitoxantrone - pharmacology | Epithelial Cells - metabolism | Carcinoma, Ductal - genetics | Carcinoma, Ductal - pathology | Epithelial Cells - drug effects | Gene Expression Regulation, Neoplastic | Cellular Senescence - drug effects | Lung Neoplasms - pathology | Mammary Glands, Human - metabolism | Carcinoma, Ductal - drug therapy | Prostate - metabolism | Breast Neoplasms - metabolism | DNA-Binding Proteins - metabolism | Resorcinols - pharmacology | Stromal Cells - drug effects | Female | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Cell Line | Carcinoma, Non-Small-Cell Lung - genetics | Stromal Cells - metabolism | Transcription Factors - antagonists & inhibitors | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Mice, SCID | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - drug therapy | TOR protein | Phenotypes | Senescence | TRAF6 protein | Complications | TAK1 protein | DNA damage | AKT protein | Pharmacology | Gene expression | Chemical compounds | Molecular chains | 1-Phosphatidylinositol 3-kinase | Side effects | Stromal cells | Regulatory mechanisms (biology) | In vivo methods and tests | Feedforward | Deoxyribonucleic acid--DNA | Refueling | Cancer | Tumors
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2012, Volume 429, Issue 1-2, pp. 87 - 92
Journal Article
Clinical and Experimental Metastasis, ISSN 0262-0898, 11/2002, Volume 19, Issue 7, pp. 639 - 649
Journal Article
Case Reports in Oncology, ISSN 1662-6575, 08/2019, Volume 12, Issue 2, pp. 681 - 687
Metastasis from salivary gland tumors to liver is exceedingly uncommon. Reported is the first case of a mammary analog secretory carcinoma (MASC) of salivary... 
Case Report | Lymphatic system | Liver | Thyroid gland | Metastasis | Disclosure | Kinases | Abdomen | Proteins | Pathology | Biopsy | Medical prognosis | Gastroenterology | Cancer | Tumors | Mammary analogue secretory carcinoma | Tyrosine-kinase inhibitor | Parotid gland tumor | Malignancy | Liver metastasis
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 10/2000, Volume 279, Issue 4, pp. 1230 - 1238
Journal Article